Clearside Biomedical Inc (NASDAQ:CLSD) shares, rose in value on Friday, December 13, with the stock price up by 2.00% to the previous day’s close as strong demand from buyers drove the stock to $1.02.
Actively observing the price movement in the last trading, the stock closed the session at $1.00, falling within a range of $0.99 and $1.05. The value of beta (5-year monthly) was 2.332. Referring to stock’s 52-week performance, its high was $2.12, and the low was $0.92. On the whole, CLSD has fluctuated by -5.56% over the past month.
With the market capitalization of Clearside Biomedical Inc currently standing at about $77.36 million, investors are eagerly awaiting this quarter’s results, scheduled for in January.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 294.43k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CLSD’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CLSD currently trading nearly -1.83% and -8.44% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.59, while the 7-day volatility ratio is showing 5.06% which for the 30-day chart, stands at 5.36%. Furthermore, Clearside Biomedical Inc (CLSD)’s beta value is 2.20, and its average true range (ATR) is 0.06.
A comparison of Clearside Biomedical Inc (CLSD) with its peers suggests the former has fared considerably weaker in the market. CLSD showed an intraday change of 2.00% in last session, and over the past year, it shrunk by -1.92%%.
Data on historical trading for Clearside Biomedical Inc (NASDAQ:CLSD) indicates that the trading volumes over the past 10 days have averaged 0.22 and over the past 3 months, they’ve averaged 715.27K. According to company’s latest data on outstanding shares, there are 74.75 million shares outstanding.
Nearly 15.29% of Clearside Biomedical Inc’s shares belong to company insiders and institutional investors own 15.96% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.76 million shares as on 2024-10-31, resulting in a short ratio of 1.21. According to the data, the short interest in Clearside Biomedical Inc (CLSD) stood at 250.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 0.26 million. The stock has fallen by -12.82% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CLSD stock heading into the next quarter.
